Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Zyga Technology SImmetry Sacroiliac Joint Fusion System wins FDA clearance

Zyga Technology has received the US Food & Drug Administration (FDA) 510(K) clearance to market its SImmetry Sacroiliac Joint Fusion System, for treating degenerative sacroiliitis and sacroiliac joint disruptions.

The SImmetry Sacroiliac Joint Fusion System consists of a range of threaded, cannulated implants and associated instrumentation.

The implants are designed to transfix the sacrum and ilium, providing stability for bony fusion.

Prairie Spine & Pain Institute Orthopedic Surgery chief Richard Kube said SImmetry is a welcome addition to his practice because it gives patients suffering from sacroiliac joint dysfunction a minimally invasive surgical treatment option.

"The SImmetry system allows surgeons to prepare the SI joint for a true arthrodesis," Kube said.

Zyga Technology president and CEO Robert Assell said they are excited for this important milestone.

"Increased awareness of SI joint disruption as a significant contributor to low back pain led us to develop a minimally invasive solution to treat this condition," Assell said.